- Redwood City, California, United States
- On-site
- Full-time · Manager
- $419K–$523K per year
Lead the late-stage clinical development strategy and oversee registrational and Phase 3 programs across the RAS(ON) portfolio.
Compensation
$419,000—$523,000 USD
Responsibilities
- Drive the late-stage clinical development strategy across the RAS(ON) portfolio
- Own registrational and Phase 3 trials across all programs and assets
- Shape indication sequencing, study design, endpoint selection and combination strategy
- Lead, develop and grow the Global Development Team Leads
- Build a late-stage organization with clear program ownership
Requirements
- MD or MD/PhD, trained as a medical oncologist
- Nice to have: depth in pancreatic, colorectal or lung cancer